Sareum Holdings PLC (LON:SAR)

Sareum Holdings PLC (LON:SAR)


Share Price
0.38 p
Change
0.0012 (0.32 %)
Market Cap
£11.55 m
Proactive Investors - Run By Investors For Investors

Sareum Holdings PLC

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

EPIC: SAR
Market: AIM:SAR
52-week High/Low: 0.93p / 0.37p
Sector: Pharma & Biotech
Market Cap: £11.55 m
Website: www.sareum.com
col 3
col 4
col 5
col 6

Sareum Holdings PLC RNS Announcements

Date Epic Announcement
28/06/2019 SAR Additional Funds Raised
27/06/2019 SAR Sierra seeks strategic options for SRA737
26/06/2019 SAR Successful Fundraising
25/06/2019 SAR PrimaryBid.com Offer
25/06/2019 SAR Placing to progress TYK2/JAK1 programmes
13/06/2019 SAR Portfolio Update
03/06/2019 SAR Key takeaways from SRA737 webcast at ASCO
03/06/2019 SAR Second Price Monitoring Extn
03/06/2019 SAR Price Monitoring Extension
03/06/2019 SAR Positive SRA737 data presented at ASCO
16/05/2019 SAR ASCO abstracts for SRA737 published
08/05/2019 SAR Sareum notes Sierra Oncology Q1 2019 Results
30/04/2019 SAR Sareum to Present at BioTrinity 2019 in London
23/04/2019 SAR SRA737 Phase I/IIa data to be presented at ASCO
02/04/2019 SAR Preclinical Data for SRA737 Presented at AACR 2019
12/03/2019 SAR Sareum Holdings PLC Issue of Options
04/03/2019 SAR HALF-YEARLY RESULTS ENDED 31 DECEMBER 2018
28/02/2019 SAR Sierra Oncology has reported its 2018 Results
28/02/2019 SAR New SRA737 preclin data to be presented at AACR
23/01/2019 SAR Sierra Oncology to present SRA737 at DDR Tx Summit
18/12/2018 SAR Results of AGM
18/12/2018 SAR AGM Statement
30/11/2018 SAR Amendment to Preclinical Efficacy Announcement
30/11/2018 SAR Preclinical Efficacy for Immunotherapy Combination
15/11/2018 SAR Preclinical Data for SRA737 in Ovarian Cancer
14/11/2018 SAR AGM NOTICE
13/11/2018 SAR Directorate Change
08/11/2018 SAR Sierra Oncology Q3 2018 Results
26/10/2018 SAR Completion of Placing
01/10/2018 SAR FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use